应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02257 圣诺医药-B
未开盘 12-08 16:08:08
7.300
+0.370
+5.34%
最高
7.660
最低
6.710
成交量
78.77万
今开
6.800
昨收
6.930
日振幅
13.71%
总市值
7.74亿
流通市值
7.74亿
总股本
1.06亿
成交额
557.00万
换手率
0.74%
流通股本
1.06亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
圣诺医药-B(02257)获主席潘洪辉增持10万股
智通财经 · 12-08 19:09
圣诺医药-B(02257)获主席潘洪辉增持10万股
圣诺医药-B(02257):部分完成根据一般授权认购新股份及终止认购协议
智通财经 · 12-07 18:17
圣诺医药-B(02257):部分完成根据一般授权认购新股份及终止认购协议
圣诺医药-B12月04日主力净流入28.1万元 散户资金抛售
市场透视 · 12-04
圣诺医药-B12月04日主力净流入28.1万元 散户资金抛售
创新药概念持续调整 歌礼制药(01672)跌逾1成 机构指仿制药下降趋势无法避免 影响制药行业
金吾财讯 · 12-03
创新药概念持续调整 歌礼制药(01672)跌逾1成 机构指仿制药下降趋势无法避免 影响制药行业
圣诺医药-B盘中异动 早盘大幅拉升5.32%报8.310港元
市场透视 · 11-26
圣诺医药-B盘中异动 早盘大幅拉升5.32%报8.310港元
圣诺医药-B盘中异动 临近午盘急速下挫5.01%报8.160港元
市场透视 · 11-18
圣诺医药-B盘中异动 临近午盘急速下挫5.01%报8.160港元
港股生物医药股持续走强!旺山旺水-B涨近30%,圣诺医药-B涨超18%
老虎资讯综合 · 11-14
港股生物医药股持续走强!旺山旺水-B涨近30%,圣诺医药-B涨超18%
圣诺医药-B盘中异动 急速拉升5.49%
市场透视 · 11-14
圣诺医药-B盘中异动 急速拉升5.49%
圣诺医药-B11月11日主力净流出21.7万元 散户资金买入
市场透视 · 11-11
圣诺医药-B11月11日主力净流出21.7万元 散户资金买入
港股生物医药板块午后走强!歌礼制药-B涨超10%,圣诺医药-B涨超8%
老虎资讯综合 · 11-10
港股生物医药板块午后走强!歌礼制药-B涨超10%,圣诺医药-B涨超8%
医药行业2025年11月月报:Q3态势良好 持续推荐创新药械产业链
国泰海通证券 · 11-06
医药行业2025年11月月报:Q3态势良好 持续推荐创新药械产业链
恒生医疗保健指数跌0.3% 医药股普遍走低 圣诺医药-B(02257)跌8.23%
金吾财讯 · 11-05
恒生医疗保健指数跌0.3% 医药股普遍走低 圣诺医药-B(02257)跌8.23%
圣诺医药-B盘中异动 急速跳水5.09%报8.760港元
市场透视 · 11-05
圣诺医药-B盘中异动 急速跳水5.09%报8.760港元
圣诺医药-B10月30日遭主力抛售26.8万元
市场透视 · 10-30
圣诺医药-B10月30日遭主力抛售26.8万元
圣诺医药-B10月28日主力净流出58.5万元 散户资金买入
市场透视 · 10-28
圣诺医药-B10月28日主力净流出58.5万元 散户资金买入
圣诺医药-B盘中异动 股价大跌5.94%报10.760港元
市场透视 · 10-28
圣诺医药-B盘中异动 股价大跌5.94%报10.760港元
圣诺医药-B(02257)完成发行105.17万股认购股份
智通财经 · 10-22
圣诺医药-B(02257)完成发行105.17万股认购股份
圣诺医药-B盘中异动 股价大涨5.15%报13.270港元
市场透视 · 10-20
圣诺医药-B盘中异动 股价大涨5.15%报13.270港元
圣诺医药-B盘中异动 急速下跌5.33%报12.600港元
市场透视 · 10-17
圣诺医药-B盘中异动 急速下跌5.33%报12.600港元
圣诺医药-B10月15日主力净流入93.5万元 散户资金抛售
市场透视 · 10-15
圣诺医药-B10月15日主力净流入93.5万元 散户资金抛售
加载更多
公司概况
公司名称:
圣诺医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
Sirnaomics Ltd是一家投资控股公司。该公司及其子公司是临床阶段的生物技术公司,从事核糖核酸干扰(RNAi)技术和多种疗法的开发和商业化。该公司致力于发现和开发针对该地区未满足医疗需求的适应症的药物。其主要临床候选药物包括STP705和STP707。其STP705是一种用于治疗非黑色素瘤皮肤癌 (NMSC) 的无菌药物产品,包括原位鳞状细胞癌和基底细胞癌 (BCC)、瘢痕疙瘩切除术后复发的瘢痕疙瘩、肥厚性瘢痕 (HTS) 和实体肝肿瘤,以及 用于医学美容。其STP707是一种无菌药物产品,用于治疗实体瘤,包括肝癌、转移性皮肤鳞状细胞皮肤癌 (cSCC) 和非小细胞肺癌。其正在利用其双重交付平台,其中包括多肽纳米颗粒 (PNP) 和GalAhead。
发行价格:
--
{"stockData":{"symbol":"02257","market":"HK","secType":"STK","nameCN":"圣诺医药-B","latestPrice":7.3,"timestamp":1765181288469,"preClose":6.93,"halted":0,"volume":787700,"delay":0,"floatShares":106000000,"shares":106000000,"eps":-5.160021472082404,"marketStatus":"未开盘","change":0.37,"latestTime":"12-08 16:08:08","open":6.8,"high":7.66,"low":6.71,"amount":5570014,"amplitude":0.137085,"askPrice":7.3,"askSize":11400,"bidPrice":7.15,"bidSize":11200,"shortable":0,"etf":0,"ttmEps":-1.263390877476875,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765243800000},"marketStatusCode":0,"adr":0,"listingDate":1640793600000,"exchange":"SEHK","adjPreClose":6.93,"openAndCloseTimeList":[[1765157400000,1765166400000],[1765170000000,1765180800000]],"volumeRatio":1.744165,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02257","defaultTab":"news","newsList":[{"id":"2589099334","title":"圣诺医药-B(02257)获主席潘洪辉增持10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589099334","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589099334?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:09","pubTimestamp":1765192184,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺医药-B(02257)公布,公司执行董事兼主席潘洪辉博士已于2025年12月8日以其个人资金于公开市场按每股股份约6.83港元的平均价格购入合共10万股公司普通股,总代价约为68.3万港元。紧随购入后,潘洪辉博士于合共17,627,696股股份中拥有权益,占公司于本公告日期已发行股本总额的16.44%。据潘洪辉博士告知,彼对集团的整体发展前景及潜在增长充满信心。在符合适用法律及监管规定的情况下,潘洪辉博士不排除彼可能会于适当时进一步增持公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2589487124","title":"圣诺医药-B(02257):部分完成根据一般授权认购新股份及终止认购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2589487124","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589487124?lang=zh_cn&edition=full","pubTime":"2025-12-07 18:17","pubTimestamp":1765102644,"startTime":"0","endTime":"0","summary":"经友好诚信协商后,公司与认购人B一致同意于2025年12月7日终止认购余下215.13万股股份。于该终止后,订约方之全部权利及义务即告失效,任何一方均不得就认购协议B向另一方提出任何索偿。认购人C未能于2025年12月7日前履行认购协议C规定之职责,公司已根据该协议条款终止认购协议C。董事会认为,终止认购协议C不会对公司现有业务、营运或财务状况产生任何重大不利影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2588889065","title":"圣诺医药-B12月04日主力净流入28.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2588889065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588889065?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836121,"startTime":"0","endTime":"0","summary":"12月04日, 圣诺医药-B股价涨1.44%,报收7.05元,成交金额198.4万元,换手率0.27%,振幅3.88%,量比0.78。圣诺医药-B今日主力资金净流入28.1万元,上一交易日主力净流出118.1万元。该股近5个交易日下跌16.67%,主力资金累计净流出132.2万元;近20日主力资金累计净流出412.3万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161622a7234d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161622a7234d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2588343016","title":"创新药概念持续调整 歌礼制药(01672)跌逾1成 机构指仿制药下降趋势无法避免 影响制药行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2588343016","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588343016?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:08","pubTimestamp":1764749332,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念持续调整,临近收盘,歌礼制药(01672)跌11.1%,圣诺医药(02257)跌10.9%,信达生物(01801)跌2.72%,药明生物(02269)跌1.8%,百济神州(06160)跌1.35%。国元国际指出,医药行业目前已经进行了十一批国家药品集中带量采购以及多轮医保谈判,随着药品带量采购的常态化进行,仿制药行业的下降趋势无法避免,对制药行业有一定的影响。2025年1-9月医药制造业实现营业收入同比略下降2.0%,利润总额同比略下降0.7%,整体比较平稳。受集采、医保谈判的影响,仿制药的前景平淡,未来行业的发展需要创新药来推动增长。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970832","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU3063872942.SGD","BK1576","02257","159992","SG9999002562.SGD","LU0502904849.HKD","LU0140636845.USD","IE00B0JY6N72.USD","LU2097828714.EUR","01672","LU1688375341.USD","LU2097828805.USD","LU0327786744.USD","HK0000165453.HKD","LU1242518857.USD","LU0307460666.USD","LU0181495838.USD","LU1242518931.SGD","BK1610","LU0417516902.SGD","06160","06978","BK1141","BK1191","LU0979878070.USD","BK1521","01477","LU1794554557.SGD","LU2097828631.EUR","LU0052750758.USD","LU2097828474.EUR","LU0588546209.SGD","LU0051755006.USD","LU0417516738.SGD","02269","LU2488822045.USD","LU0823426308.USD","LU0516423174.USD","LU0039217434.USD","LU0455707207.USD","LU1720050803.USD","LU1880383366.USD","LU0819121731.USD","LU2039709279.SGD","LU0516422440.USD","LU0516422952.EUR","BK1161","LU1303224171.USD","LU1770034418.SGD"],"gpt_icon":0},{"id":"2586813552","title":"圣诺医药-B盘中异动 早盘大幅拉升5.32%报8.310港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586813552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586813552?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:30","pubTimestamp":1764124200,"startTime":"0","endTime":"0","summary":"2025年11月26日早盘10时30分,圣诺医药-B股票出现异动,股价大幅拉升5.32%。截至发稿,该股报8.310港元/股,成交量15.3315万股,换手率0.14%,振幅5.32%。资金方面,该股资金流入98.7753万港元,流出21.3476万港元。圣诺医药-B股票所在的生物技术行业中,整体涨幅为3.47%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126103000977fbe02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126103000977fbe02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2584983552","title":"圣诺医药-B盘中异动 临近午盘急速下挫5.01%报8.160港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584983552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584983552?lang=zh_cn&edition=full","pubTime":"2025-11-18 11:59","pubTimestamp":1763438354,"startTime":"0","endTime":"0","summary":"2025年11月18日临近午盘11时59分,圣诺医药-B股票出现异动,股价大幅下跌5.01%。截至发稿,该股报8.160港元/股,成交量29.5万股,换手率0.28%,振幅4.07%。资金方面,该股资金流入76.1002万港元,流出167.059万港元。圣诺医药-B股票所在的生物技术行业中,整体涨幅为0.34%。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118115914950b505b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118115914950b505b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"1143322445","title":"港股生物医药股持续走强!旺山旺水-B涨近30%,圣诺医药-B涨超18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143322445","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143322445?lang=zh_cn&edition=full","pubTime":"2025-11-14 11:20","pubTimestamp":1763090400,"startTime":"0","endTime":"0","summary":"11月14日,港股$生物(000504)$医药股盘中逆势拉升,$基石药业-B(02616)$涨超11%,$歌礼制药-B(01672)$涨超9%,$圣诺医药-B(02257)$、$来凯医药-B(02105)$涨近7%,$派格生物医药-B(02565)$、$永泰生物-B(06978)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5d27790606b64b3231c65f4df87c0e89","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02257","01672","02616","02630"],"gpt_icon":0},{"id":"2583393576","title":"圣诺医药-B盘中异动 急速拉升5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583393576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583393576?lang=zh_cn&edition=full","pubTime":"2025-11-14 10:04","pubTimestamp":1763085898,"startTime":"0","endTime":"0","summary":"2025年11月14日早盘10时04分,圣诺医药-B股票出现异动,股价急速上涨5.49%。截至发稿,该股报8.450港元/股,成交量4.685万股,换手率0.04%,振幅6.87%。圣诺医药-B股票所在的生物技术行业中,整体跌幅为2.48%。其相关个股中,基石药业-B、歌礼制药-B、迈博药业-B涨幅较大,振幅较大的相关个股有嘉和生物-B、基石药业-B、帝王国际投资,振幅分别为10.03%、9.65%、9.46%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114100458976855cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114100458976855cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2582348336","title":"圣诺医药-B11月11日主力净流出21.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2582348336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582348336?lang=zh_cn&edition=full","pubTime":"2025-11-11 16:15","pubTimestamp":1762848930,"startTime":"0","endTime":"0","summary":"11月11日, 圣诺医药-B股价跌1.66%,报收7.70元,成交金额178.6万元,换手率0.22%,振幅4.09%,量比0.40。圣诺医药-B今日主力资金净流出21.7万元,上一交易日主力净流出0万元。该股近5个交易日下跌16.58%,主力资金累计净流入5.0万元;近20日主力资金累计净流入354.2万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111116172494fd3520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111116172494fd3520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"1133726470","title":"港股生物医药板块午后走强!歌礼制药-B涨超10%,圣诺医药-B涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133726470","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133726470?lang=zh_cn&edition=full","pubTime":"2025-11-10 14:00","pubTimestamp":1762754453,"startTime":"0","endTime":"0","summary":"11月10日,港股生物医药板块午后走强,$歌礼制药-B(01672)$涨超10%,$圣诺医药-B(02257)$涨超8%,银诺医药-B、开拓药业-B、$劲方医药-B(02595)$、$映恩生物-B(09606)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"afa821d7c5aabc22fa508f3ca44a801f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","02595","09939","01672","09606","01477","02257"],"gpt_icon":0},{"id":"2581059517","title":"医药行业2025年11月月报:Q3态势良好 持续推荐创新药械产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2581059517","media":"国泰海通证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581059517?lang=zh_cn&edition=full","pubTime":"2025-11-06 00:00","pubTimestamp":1762358400,"startTime":"0","endTime":"0","summary":"本报告导读:医药板块2025Q3 复苏态势良好,继续推荐创新药械及产业链。并将上述标的纳入国泰海通医药2025 年11 月月度组合。医药板块2025Q3 复苏态势良好。2025Q3 医药板块整体收入同比增长0.6%,归母净利润同比增长0.3%,收入同比增速转正,复苏态势良好。截至2025 年10 月底,医药板块相对于全部A 股的溢价水平目前处于正常水平,当前相对溢价率76.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106152655975798f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106152655975798f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0502904849.HKD","BK1574","LU2242644610.SGD","BK1589","09939","LU0455707207.USD","02257","LU2488822045.USD","LU1969619763.USD","01801","LU2097828631.EUR","LU2097828557.USD","LU2097828714.EUR","BK1583","BK1515","BK1161","LU2097828805.USD","LU2328871848.SGD","LU2097828474.EUR"],"gpt_icon":0},{"id":"2581061713","title":"恒生医疗保健指数跌0.3% 医药股普遍走低 圣诺医药-B(02257)跌8.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581061713","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581061713?lang=zh_cn&edition=full","pubTime":"2025-11-05 11:14","pubTimestamp":1762312498,"startTime":"0","endTime":"0","summary":"金吾财讯 | 恒生医疗保健指数日内跌0.3%,医药股普遍走低,圣诺医药-B(02257)跌8.23%,百奥赛图-B(02315)跌5.63%,荣昌生物(09995)跌4.73%,药明巨诺-B(02126)、科笛-B(02487)跌逾4%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969055","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU1969619763.USD","02126","02315","LU2328871848.SGD","09939","BK1574","159506","159938","09995","02487","BK1515","BK1161","02257"],"gpt_icon":0},{"id":"2581152717","title":"圣诺医药-B盘中异动 急速跳水5.09%报8.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581152717","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581152717?lang=zh_cn&edition=full","pubTime":"2025-11-05 10:02","pubTimestamp":1762308137,"startTime":"0","endTime":"0","summary":"2025年11月05日早盘10时02分,圣诺医药-B股票出现波动,股价大幅下挫5.09%。截至发稿,该股报8.760港元/股,成交量5.22万股,换手率0.05%,振幅4.01%。资金方面,该股资金流入13.5343万港元,流出28.8165万港元。圣诺医药-B股票所在的生物技术行业中,整体涨幅为1.13%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511051002179754acdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511051002179754acdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2579890944","title":"圣诺医药-B10月30日遭主力抛售26.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579890944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579890944?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:15","pubTimestamp":1761812151,"startTime":"0","endTime":"0","summary":"10月30日, 圣诺医药-B股价跌5.78%,报收9.61元,成交金额541.2万元,换手率0.52%,振幅7.94%,量比1.05。圣诺医药-B今日主力资金净流出26.8万元,上一交易日主力净流出58.5万元。该股近5个交易日下跌22.06%,主力资金累计净流入161.9万元;近20日主力资金累计净流出136.4万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030162118a6d655ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030162118a6d655ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2579323960","title":"圣诺医药-B10月28日主力净流出58.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2579323960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579323960?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:15","pubTimestamp":1761639327,"startTime":"0","endTime":"0","summary":"10月28日, 圣诺医药-B股价跌10.84%,报收10.20元,成交金额976.0万元,换手率0.89%,振幅14.95%,量比2.58。圣诺医药-B今日主力资金净流出58.5万元,上一交易日主力净流入43.6万元。该股近5个交易日下跌18.07%,主力资金累计净流入219.5万元;近20日主力资金累计净流出275.7万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028161755a479419d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028161755a479419d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2579296037","title":"圣诺医药-B盘中异动 股价大跌5.94%报10.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579296037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579296037?lang=zh_cn&edition=full","pubTime":"2025-10-28 10:45","pubTimestamp":1761619531,"startTime":"0","endTime":"0","summary":"2025年10月28日早盘10时45分,圣诺医药-B股票出现异动,股价大幅下跌5.94%。截至发稿,该股报10.760港元/股,成交量11.47万股,换手率0.11%,振幅8.30%。资金方面,该股资金流入22.3879万港元,流出78.4266万港元。圣诺医药-B股票所在的生物技术行业中,整体跌幅为1.01%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028104531a6d1cd50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028104531a6d1cd50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2577279350","title":"圣诺医药-B(02257)完成发行105.17万股认购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2577279350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577279350?lang=zh_cn&edition=full","pubTime":"2025-10-22 18:21","pubTimestamp":1761128480,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺医药-B(02257)发布公告,于2025年10月22日,该公司根据2025年9月7日的认购协议,完成根据一般授权认购新股份后发行105.17万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2577891359","title":"圣诺医药-B盘中异动 股价大涨5.15%报13.270港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577891359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577891359?lang=zh_cn&edition=full","pubTime":"2025-10-20 09:31","pubTimestamp":1760923901,"startTime":"0","endTime":"0","summary":"2025年10月20日早盘09时31分,圣诺医药-B股票出现波动,股价急速拉升5.15%。截至发稿,该股报13.270港元/股,成交量2250股,换手率0.00%,振幅2.38%。资金方面,该股资金流入1.5115万港元,流出5971.5港元。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。圣诺医药-B股票所在的生物技术行业中,整体涨幅为5.73%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102009314194d2d912&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102009314194d2d912&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2576050712","title":"圣诺医药-B盘中异动 急速下跌5.33%报12.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576050712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576050712?lang=zh_cn&edition=full","pubTime":"2025-10-17 15:59","pubTimestamp":1760687989,"startTime":"0","endTime":"0","summary":"2025年10月17日临近收盘15时59分,圣诺医药-B股票出现波动,股价大幅下挫5.33%。截至发稿,该股报12.600港元/股,成交量42.905万股,换手率0.41%,振幅6.24%。资金方面,该股资金流入234.566万港元,流出307.168万港元。圣诺医药-B股票所在的生物技术行业中,整体跌幅为2.17%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101715594997338678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101715594997338678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2575747769","title":"圣诺医药-B10月15日主力净流入93.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2575747769","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575747769?lang=zh_cn&edition=full","pubTime":"2025-10-15 16:15","pubTimestamp":1760516121,"startTime":"0","endTime":"0","summary":"10月15日, 圣诺医药-B股价涨1.59%,报收12.80元,成交金额775.3万元,换手率0.59%,振幅6.51%,量比0.90。圣诺医药-B今日主力资金净流入93.5万元,上一交易日主力净流出151.6万元。该股近5个交易日下跌17.21%,主力资金累计净流出384.8万元;近20日主力资金累计净流出400.4万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015161636a6ba6d3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015161636a6ba6d3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.sirnaomics.com/en/","stockEarnings":[{"period":"1week","weight":-0.1032},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.646},{"period":"6month","weight":0.7633},{"period":"1year","weight":1.7037},{"period":"ytd","weight":1.1098}],"compareEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":-0.0182},{"period":"3month","weight":-0.0067},{"period":"6month","weight":0.0574},{"period":"1year","weight":0.297},{"period":"ytd","weight":0.2844}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Sirnaomics Ltd是一家投资控股公司。该公司及其子公司是临床阶段的生物技术公司,从事核糖核酸干扰(RNAi)技术和多种疗法的开发和商业化。该公司致力于发现和开发针对该地区未满足医疗需求的适应症的药物。其主要临床候选药物包括STP705和STP707。其STP705是一种用于治疗非黑色素瘤皮肤癌 (NMSC) 的无菌药物产品,包括原位鳞状细胞癌和基底细胞癌 (BCC)、瘢痕疙瘩切除术后复发的瘢痕疙瘩、肥厚性瘢痕 (HTS) 和实体肝肿瘤,以及 用于医学美容。其STP707是一种无菌药物产品,用于治疗实体瘤,包括肝癌、转移性皮肤鳞状细胞皮肤癌 (cSCC) 和非小细胞肺癌。其正在利用其双重交付平台,其中包括多肽纳米颗粒 (PNP) 和GalAhead。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.166818},{"month":2,"riseRate":0.75,"avgChangeRate":-0.005191},{"month":3,"riseRate":0.25,"avgChangeRate":-0.121551},{"month":4,"riseRate":0.25,"avgChangeRate":-0.056034},{"month":5,"riseRate":0.5,"avgChangeRate":0.03445},{"month":6,"riseRate":0.75,"avgChangeRate":-0.008205},{"month":7,"riseRate":0.75,"avgChangeRate":0.15893},{"month":8,"riseRate":0.25,"avgChangeRate":-0.085891},{"month":9,"riseRate":0.75,"avgChangeRate":0.238751},{"month":10,"riseRate":0,"avgChangeRate":-0.180246},{"month":11,"riseRate":0,"avgChangeRate":-0.082953},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003101}],"exchange":"SEHK","name":"圣诺医药-B","nameEN":"SIRNAOMICS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺医药-B,02257,圣诺医药-B股票,圣诺医药-B股票老虎,圣诺医药-B股票老虎国际,圣诺医药-B行情,圣诺医药-B股票行情,圣诺医药-B股价,圣诺医药-B股市,圣诺医药-B股票价格,圣诺医药-B股票交易,圣诺医药-B股票购买,圣诺医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}